BioCentury
ARTICLE | Company News

Medgenics management update

August 20, 2012 7:00 AM UTC

Medgenics Inc. (LSE:MEDU; NYSE-M:MDGN), Vienna, Va. Business: Gene/Cell therapy, Drug delivery Transitioned: Marvin Garovoy to CMO from acting CMO ...